(Q39105148)

9 September 2017

title

Bortezomib induces apoptosis and autophagy in osteosarcoma cells through mitogen-activated protein kinase pathway in vitro (English)

1 reference

9 September 2017

0 references

Zhiyuan Lou

1

1 reference

9 September 2017

Tingting Ren

2

1 reference

9 September 2017

Xianbo Peng

3

1 reference

9 September 2017

Yifeng Sun

4

1 reference

9 September 2017

Guangjun Jiao

5

1 reference

9 September 2017

Qunshan Lu

6

1 reference

9 September 2017

Shuai Zhang

7

1 reference

9 September 2017

Xinchang Lu

8

1 reference

9 September 2017

Wei Guo

9

1 reference

9 September 2017

language of work or name

1 reference

23 August 2013

1 reference

Journal of International Medical Research

9 September 2017

published in

1 reference

9 September 2017

volume

41

1 reference

9 September 2017

issue

5

1 reference

9 September 2017

page(s)

1505-1519

1 reference

The epidemiology of osteosarcoma

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

Targeting hedgehog-GLI-2 pathway in osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

Targeting the ubiquitin-proteasome pathway with inorganic compounds to fight cancer: a challenge for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

United States Food and Drug Administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

The proteasome: a suitable antineoplastic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

Autophagy preceded apoptosis in oridonin-treated human breast cancer MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

Apoptosis, autophagy, and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

Signal integration by JNK and p38 MAPK pathways in cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

Proteasome inhibitor Bortezomib induces cell cycle arrest and apoptosis in cell lines derived from Ewing's sarcoma family of tumors and synergizes with TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

Proteasome inhibition with bortezomib suppresses growth and induces apoptosis in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

FoxM1 knockdown sensitizes human cancer cells to proteasome inhibitor-induced apoptosis but not to autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

3-Methyladenine, an inhibitor of autophagy, has multiple effects on metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

MAPK signal pathways in the regulation of cell proliferation in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

p38 mitogen-activated protein kinase inhibitors--mechanisms and therapeutic potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

Targeting NF-kappaB in Waldenstrom macroglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513490618

21 January 2018

Identifiers

DOI

10.1177/0300060513490618

1 reference

9 September 2017

1 reference